Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 5
2006 1
2008 1
2009 1
2010 1
2011 3
2012 6
2013 10
2014 2
2015 8
2016 11
2017 12
2018 11
2019 8
2020 25
2021 31
2022 16
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Results by year
Filters applied: . Clear all
Page 1
Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration.
Cohen SY, Dominguez M, Coscas F, Faure C, Baillif S, Oubraham H, Kodjikian L, Weber M; RAINBOW study investigators. Cohen SY, et al. Among authors: baillif s. Graefes Arch Clin Exp Ophthalmol. 2022 Nov 18. doi: 10.1007/s00417-022-05900-6. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 36399178
Recent Advances in Age-Related Macular Degeneration Therapies.
Fabre M, Mateo L, Lamaa D, Baillif S, Pagès G, Demange L, Ronco C, Benhida R. Fabre M, et al. Among authors: baillif s. Molecules. 2022 Aug 10;27(16):5089. doi: 10.3390/molecules27165089. Molecules. 2022. PMID: 36014339 Free PMC article. Review.
129 results